TCT-231 World’s First Series of Left Main Bifurcation Treated with the AXXESS 4.0 x 9 mm Dedicated Bifurcation Stent
Omer Rana(Cardiff University), Peter O’Kane(Royal Bournemouth Hospital), Suneel Talwar(Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust), Sanjay Sastry(Manchester Royal Infirmary), Jehangir Din(Royal Bournemouth Hospital), Farzin Fath‐Ordoubadi(University of Manchester), Mamas Mamas(Keele University)
Cited by 0
Related Papers
Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial
|The Lancet|2017|1k
Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction
|New England Journal of Medicine|2022|566
OCT or Angiography Guidance for PCI in Complex Bifurcation Lesions
|New England Journal of Medicine|2023|341
Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study
|European Heart Journal|2017|295
A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina
|New England Journal of Medicine|2023|223